Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

What age range was the majority of polivy's clinical trial participants in?

See the DrugPatentWatch profile for polivy

What age range made up the majority of participants in polivy's clinical trials?

Polivy is a medication used to treat cancer, specifically diffuse large B-cell lymphoma (DLBCL).

According to the clinical trial results [1] on ClinicalTrials.gov, the majority of participants in the clinical trials for Polivy (polaratumab) were within the age range of 18-64 years.

A clinical trial conducted on 305 adults suffering from heavily pretreated diffuse large B-cell lymphoma (DLBCL) reported that the median age of participants was 65 years, with a range of 18-93 years [2].



Other Questions About Polivy :

Has polivy's progression free survival rate improved in recent clinical trials? What were polivy s response rates in trials? Can you name the comparison drug used with polivy? Were older adults included in polivy's clinical trials? What was the age range of polivy trial participants? Which comparison drug was used in polivy s trials? Which patient groups were part of polivy's trials?